INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,122,000 | -30.3% | 1,427,300 | 0.0% | 0.06% | -28.6% |
| Q3 2021 | $10,219,000 | -22.8% | 1,427,300 | 0.0% | 0.08% | -12.5% |
| Q2 2021 | $13,231,000 | +132.3% | 1,427,300 | +132.6% | 0.10% | +108.7% |
| Q1 2021 | $5,695,000 | +109.0% | 613,700 | +99.3% | 0.05% | +283.3% |
| Q4 2020 | $2,725,000 | -40.3% | 307,900 | -21.8% | 0.01% | -58.6% |
| Q3 2020 | $4,566,000 | -79.6% | 393,600 | -52.5% | 0.03% | -84.8% |
| Q2 2020 | $22,345,000 | +378.7% | 829,100 | +32.1% | 0.19% | +189.4% |
| Q1 2020 | $4,668,000 | – | 627,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Triatomic Management LP | 235,000 | $405,000 | 0.23% |
| Green Alpha Advisors, LLC | 147,380 | $254,000 | 0.22% |
| Financial Advocates Investment Management | 14,161 | $628,000 | 0.05% |
| Virtus ETF Advisers LLC | 72,540 | $125,000 | 0.05% |
| Cedar Brook Financial Partners, LLC | 88,750 | $153,094 | 0.05% |
| Rafferty Asset Management, LLC | 2,363,189 | $4,077,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 352,721 | $608,000 | 0.04% |
| CAXTON ASSOCIATES LP | 130,728 | $226,000 | 0.03% |
| Keystone Financial Group | 74,058 | $128,000 | 0.03% |
| Virtu Financial LLC | 130,829 | $226,000 | 0.02% |